|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Silvestri GA, Alberg AJ and Ravenel J: The
changing epidemiology of lung cancer with a focus on screening.
BMJ. 339:b30532009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brahimi-Horn C and Pouysségur J: The role
of the hypoxia-inducible factor in tumor metabolism growth and
invasion. Bull Cancer. 93:E73–E80. 2006.PubMed/NCBI
|
|
4
|
Fraga A, Ribeiro R and Medeiros R: Tumor
hypoxia: the role of HIF. Actas Urol Esp. 33:941–951. 2009.(In
Spanish).
|
|
5
|
Cassavaugh J and Lounsbury KM:
Hypoxia-mediated biological control. J Cell Biochem. 112:735–744.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
DeClerck K and Elble RC: The role of
hypoxia and acidosis in promoting metastasis and resistance to
chemotherapy. Front Biosci. 15:213–225. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wilson WR and Hay MP: Targeting hypoxia in
cancer therapy. Nat Rev Cancer. 11:393–410. 2011. View Article : Google Scholar
|
|
8
|
Assinder SJ, Stanton JA and Prasad PD:
Transgelin: an actin-binding protein and tumour suppressor. Int J
Biochem Cell Biol. 41:482–486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lambrechts A, Van Troys M and Ampe C: The
actin cytoskeleton in normal and pathological cell motility. Int J
Biochem Cell Biol. 36:1890–1909. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang R, Zhou L, Li Q, Liu J, Yao W and
Wan H: Up-regulation of two actin-associated proteins prompts
pulmonary artery smooth muscle cell migration under hypoxia. Am J
Respir Cell Mol Biol. 41:467–475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang Q, Chen W, Wang L, Lin W, Lin J and
Lin X: Identification of transgelin as a potential novel biomarker
for gastric adenocarcinoma based on proteomics technology. J Cancer
Res Clin Oncol. 134:1219–1227. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ryu JW, Kim HJ, Lee YS, et al: The
proteomics approach to find biomarkers in gastric cancer. J Korean
Med Sci. 18:505–509. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mikuriya K, Kuramitsu Y, Ryozawa S, et al:
Expression of glycolytic enzymes is increased in pancreatic
cancerous tissues as evidenced by proteomic profiling by
two-dimensional electrophoresis and liquid chromatography-mass
spectrometry/mass spectrometry. Int J Oncol. 30:849–855. 2007.
|
|
14
|
Arvelo F and Cotte C: Hypoxia in cancer
malignity. Review. Invest Clin. 50:529–546. 2009.(In Spanish).
|
|
15
|
Subarsky P and Hill RP: The hypoxic tumour
microenvironment and metastatic progression. Clin Exp Metastasis.
20:237–250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giatromanolaki A and Harris AL: Tumour
hypoxia, hypoxia signaling pathways and hypoxia inducible factor
expression in human cancer. Anticancer Res. 21:4317–4324.
2001.PubMed/NCBI
|
|
17
|
Shapland C, Hsuan JJ, Totty NF and Lawson
D: Purification and properties of transgelin: a transformation and
shape change sensitive actin-gelling protein. J Cell Biol.
121:1065–1073. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fu Y, Liu HW, Forsythe SM, et al:
Mutagenesis analysis of human SM22: characterization of actin
binding. J Appl Physiol. 89:1985–1990. 2000.PubMed/NCBI
|
|
19
|
Shanahan CM, Weissberg PL and Metcalfe JC:
Isolation of gene markers of differentiated and proliferating
vascular smooth muscle cells. Circ Res. 73:193–204. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu H, Königshoff M, Jayachandran A, et al:
Transgelin is a direct target of TGF-beta/Smad3-dependent
epithelial cell migration in lung fibrosis. FASEB J. 22:1778–1789.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gimona M, Kaverina I, Resch GP, Vignal E
and Burgstaller G: Calponin repeats regulate actin filament
stability and formation of podosomes in smooth muscle cells. Mol
Biol Cell. 14:2482–2491. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamaguchi H and Condeelis J: Regulation of
the actin cytoskeleton in cancer cell migration and invasion.
Biochim Biophys Acta. 1773:642–652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao L, Wang H, Deng YJ, Wang S, Liu C,
Jin H and Ding YQ: Transgelin as a suppressor is associated with
poor prognosis in colorectal carcinoma patients. Mod Pathol.
22:786–796. 2009.PubMed/NCBI
|
|
24
|
Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y,
Chen Z, Chen YL, Yao JL, di Sant’Agnese PA and Chang C: Transgelin
functions as a suppressor via inhibition of ARA54-enhanced androgen
receptor transactivation and prostate cancer cell growth. Mol
Endocrinol. 21:343–358. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi YY, Wang HC, Yin YH, et al:
Identification and analysis of tumour-associated antigens in
hepatocellular carcinoma. Br J Cancer. 92:929–934. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou L, Zhang R, Zhang L, Sun Y, Yao W,
Zhao A, Li J and Yuan Y: Upregulation of transgelin is an
independent factor predictive of poor prognosis in patients with
advanced pancreatic cancer. Cancer Sci. 104:4234302013. View Article : Google Scholar
|
